基于这些结果,研究者认为Attana QCM技术不仅可用于挑选诊断和治疗中的最佳生物制剂,还能用于开发新型高亲和力的药物。(Clausen, T. M., et al. Real-time and label free determination of ligand binding-kinetics to primary cancer tissue specimens; a novel tool for the assessment of biomarker targeting. Sens Biosensing Res. 2016; 9: 23-30.)